Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Psychiatry (Edgmont (Pa. : Township))|September 1, 2010
Using daily interactive voice response assessments: to measure onset of symptom improvement with duloxetineHeidi K Moore, Madelaine M Wohlreich, Michael G Wilson, et al.
Biological Psychiatry|April 23, 2003
Assessing and interpreting treatment effects in longitudinal clinical trials with missing dataCraig H Mallinckrodt, Todd M Sanger, Sanjay Dubé, et al.
Neurology and Therapy|September 17, 2024
Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying TherapiesSamuel P Dickson, Craig H Mallinckrodt, Basia Rogula, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorderPedro L Delgado, Stephen K Brannan, Craig H Mallinckrodt, et al.
The Journal of Clinical Psychiatry|December 29, 2007
A comparison of initial duloxetine dosing strategies in patients with major depressive disorderVirgil G Whitmyer, David L Dunner, Susan G Kornstein, et al.
NEJM Evidence|April 22, 2025
Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular EdemaSharon Klier, Jamie Dananberg, Lauren Masaki, et al.
Cancer Investigation|July 4, 2002
Evaluation of cisplatin in combination with a biologic response modifier in a murine mammary carcinoma modelEmanuela Morello, William S Dernell, Charles A Kuntz, et al.
The Journal of Clinical Psychiatry|February 6, 2009
A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapySusan G Kornstein, David L Dunner, Adam L Meyers, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 27, 2025
Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's diseaseGarrett B Duncan, Samuel P Dickson, Johanne M Kaplan, et al.
Pageof 6